Aged garlic extract supplemented with B vitamins, folic acid and l-arginine retards the progression of subclinical atherosclerosis: A randomized clinical trial

Preventive Medicine

Volumn 49, Issue 2-3, 2009, Pages 101-107

  Budoff, Matthew J ^a   Ahmadi, Naser ^a   Gul, Khawar M ^a   Liu, Sandy T ^a   Flores, Ferdinand R ^a   Tiano, Jima ^a   Takasu, Junichiro ^a   Miller, Elizabeth ^b   Tsimikas, Sotirios ^b  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Cardiac CT; Complementary medicine; Coronary artery calcium; Progression; Randomized clinical trial

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; ARGININE; AUTOANTIBODY; C REACTIVE PROTEIN; CALCIUM; CYANOCOBALAMIN; FOLIC ACID; GARLIC EXTRACT; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; KYOLIC 108; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PHOSPHOLIPID; PLACEBO; PYRIDOXINE; UNCLASSIFIED DRUG; VITAMIN B GROUP;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

AGED; ARGININE; BIOLOGICAL MARKERS; BLOOD PRESSURE; CORONARY ARTERY DISEASE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; GARLIC; HUMANS; LIPIDS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; VITAMIN B 12; VITAMIN B COMPLEX;

EID: 70349295182     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2009.06.018     Document Type: Article

References (51)

1. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte Jr. M., and Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15 (1990) 827-832
2. Ahmadi N., Gul K., Hajsadeghi F., et al. Fingertip thermal reactivity correlated with Framingham risk score. J. Cardiovasc. Comput. Tomogr. 1 1 (2007) S13
3. Ahmadi N., Hajsadeghi F., Gul K., et al. Digital thermal monitoring of vascular function is associated with coronary artery calcification in asymptomatic adults. Circulation 117 (2008) e409-e468
4. Ahmadi N., Shim J., Vasinrapee P., et al. Vascular dysfunction measured by digital thermal monitoring is associated with myocardial perfusion defect. Circulation 117 (2008) e409-e468
5. Ahmadi N., Usman N., Shim J., et al. Vascular dysfunction measured by fingertip thermal monitoring is associated with the extent of myocardial perfusion defect. J. Nucl. Cardiol. (2009)
6. Bergmark C., Dewan A., Orsoni A., et al. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J. Lipid Res. 49 (2008) 2230-2239
7. Briley-Saebo K.C., Shaw P.X., Mulder W.J., et al. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation 117 (2008) 3206-3215
8. Budoff M. Aged garlic extract retards progression of coronary artery calcification. J. Nutr. 136 (2006) 741S-744S
9. Budoff M.J., Takasu J., Flores F.R., et al. Inhibiting Progression of coronary calcification using aged garlic extract in patients receiving statin therapy: a preliminary study. Prev. Med. 39 (2004) 985-991
10. Budoff M.J., Achenbach S., Blumenthal R.S., et al. Assessment of coronary artery disease by cardiac computed tomography, a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 114 16 (2006) 1761-1791
11. Budoff M.J., Shaw L.J., Liu S.T., et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J. Am. Coll. Cardiol. 49 (2007) 1860-1870
12. Campbell J.H., Efendy J.L., Smith N.J., and Campbell G.R. Molecular basis by which garlic suppresses atherosclerosis. J. Nutr. 131 (2001) 1006S-1009S
13. Choi S.H., Chae A., Miller E., et al. Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study. J. Am. Coll. Cardiol. 52 (2008) 24-32
14. Davignon J., and Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 109 III (2004) 27-32
15. Detrano R., Guerci A.D., Carr J.J., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N. Engl. J. Med. 358 (2008) 1336-1345
16. Dhawan V., and Jain S. Effect of garlic supplementation on oxidized low density lipoproteins and lipid peroxidation in patients of essential hypertension. Mol. Cell. Biochem. 266 (2004) 109-115
17. Dillon S.A., Burmi R.S., Lowe G.M., Billington D., and Rahman K. Antioxidant properties of aged garlic extract: an in vitro study incorporating human low density lipoprotein. Life Sci. 72 14 (2003) 1583-1594
18. Fraley A.E., and Tsimikas S. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Curr. Opin. Lipidol. 17 (2006) 502-509
19. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
20. Gonen A., Harats D., Rabinkov A., et al. The antiatherogenic effect of allicin: possible mode of action. Pathobiology 72 (2005) 325-334
21. Holvoet P., Mertens A., Verhamme P., et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 844-848
22. Ho S.E., Ide N., and Lau B.H. S-allyl cysteine reduces oxidant load in cells involved in the atherogenic process. Phytomedicine 8 (2001) 39-46
23. Ide N., Keller C., and Weiss N. Aged garlic extract inhibits homocysteine-induced CD36 expression and foam cell formation in human macrophages. J. Nutr. 136 (2006) 755S-758S
24. Itabe H., and Ueda M. Measurement of plasma oxidized low-density lipoprotein and its clinical implications. J. Atheroscler. Thromb. 14 (2007) 1-11
25. Ky B., Burke A., Tsimikas S., et al. The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans. J. Am. Coll. Cardiol. 51 (2008) 1653-1662
26. Lau B.H. Suppression of LDL oxidation by garlic. J. Nutr. 131 (2001) 985S-988S
27. Miyazaki T., Shimada K., Sato O., et al. Daida H. Circulating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease. Atherosclerosis 179 (2005) 139-145
28. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 9263 (2001) 1191-1194
29. Morihara N., Sumioka I., Moriguchi T., Uda N., and Kyo E. Aged garlic extract enhances production of nitric oxide. Life Sci. 71 (2002) 509-517
30. Nakaishi T., Tamura A., Watanabe T., Mikuriya Y., and Nasu M. Relationship between plasma oxidized low-density lipoprotein and the coronary vasomotor response to acetylcholine in patients with coronary artery disease. Jpn. Circ. J. 64 (2000) 856-860
31. Neil A., Silagy C., Lancaster T., et al. Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis. J. R. Coll. Physicians Lond. 30 (1996) 329-334
32. Okuhara T. A clinical study of garlic extract on peripheral circulation. Jpn. Pharmacol. Ther. 22 (1994) 3695-3701
33. Okuhira M., Holbert H., Sandhu R., and Steiner M. Modification of Cardiovascular Risk Factors by Aged Garlic Extract (AGE). Phytomedicine 7 (2000) 49-50
34. Raggi P., Callister T.Q., and Shaw L.J. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1272-1277
35. Rahman K., and Billington D. Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. J. Nutr. 130 (2000) 2662-2665
36. Rasouli L., Budoff M.J., Park R., and Aziz D.C. Plasma homocysteine predicts progression of atherosclerosis. Atherosclerosis 181 (2005) 159-165
37. Rodenburg J., Vissers M.N., Wiegman A., et al. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin. J. Am. Coll. Cardiol. 47 (2006) 1803-1810
38. Rosen R.T., Hiserodt R.D., Fukuda E.K., et al. Determination of allicin, S-allylcysteine and volatile metabolites of garlic in breath, plasma or simulated gastric fluids. J. Nutr. 131 (2001) 968S-971S
39. Silaste M.L., Rantala M., Alfthan G., et al. Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a). Arterioscler. Thromb. Vasc. Biol. 24 (2004) 498-503
40. Simons D.B., Schwartz R.S., Edwards W.D., Sheedy P.F., Breen J.F., and Rumberger J.A. Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study. J. Am. Coll. Cardiol. 20 (1992) 1118-1126
41. Steiner M., and Lin R.I. Changes in platelet function and susceptibility of lipoproteins to oxidation associated with administration of aged garlic extract. J. Cardiovasc. Pharmacol. 31 (1998) 904-908
42. Steiner M., Kham A.H., Holbert D., and Lin R.I.S. A double-blind crossover study in moderately hypercholesteremic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am. J. Clin. Nutr. 64 (1996) 866-870
43. Tsimikas S., Lau H.K., Han K.R., et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 109 (2004) 3164-3170
44. Tsimikas S., Witztum J.L., Miller E.R., et al. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial. Circulation 110 (2004) 1406-1412
45. Tsimikas S., Brilakis E.S., Miller E.R., et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N. Engl. J. Med. 353 (2005) 46-57
46. Tsimikas S., Kiechl S., Willeit J., et al. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study. J. Am. Coll. Cardiol. 47 (2006) 2219-2228
47. Tsimikas S., Aikawa M., Miller Jr. F.J., et al. Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 175-181
48. Tsimikas S., Brilakis E.S., Lennon R.J., et al. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J. Lipid Res. 48 (2007) 425-433
49. Warshafsky S., Kamer R.S., and Sivak S.L. Effect of garlic on total Cholesterol, a meta-analysis. Ann. Int. Med. 119 (1993) 599-605
50. Williams M.J., Sutherland W.H., McCormick M.P., Yeoman D.J., and de Jong S.A. Aged garlic extract improves vascular function in men with coronary artery disease. Phytother. Res. 19 (2005) 314-319
51. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847